Cidara Therapeutics
CDTX
CDTX
50 hedge funds and large institutions have $63.3M invested in Cidara Therapeutics in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
28% more funds holding
Funds holding: 39 → 50 (+11)
0.21% less ownership
Funds ownership: 2.7% → 2.5% (-0.21%)
Holders
50
Holding in Top 10
4
Calls
$18K
Puts
–
Top Buyers
| 1 | +$688K | |
| 2 | +$658K | |
| 3 | +$555K | |
| 4 |
Renaissance Technologies
New York
|
+$461K |
| 5 |
Millennium Management
New York
|
+$364K |
Top Sellers
| 1 | -$535K | |
| 2 | -$199K | |
| 3 | -$70.3K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$38K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$24.3K |